Header cover image
  • Investing Ideas
  • Saudi Arabian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Saudi Arabian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Results

1

1 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Saudi Pharmaceutical Industries and Medical Appliances

Market Cap: ر.س3.5b

Develops, manufactures, and markets medicinal and pharmaceutical products in the Kingdom of Saudi Arabia, the Middle East, Egypt, Algeria, and Morocco.

New

2070

ر.س29.40

7D

-2.1%

1Y

18.5%